AppointmentsNew Medical Director Appointed At UK Cannabis Company AltoVerde

New Medical Director Appointed At UK Cannabis Company AltoVerde

-

MULTIFACETED cannabis company AltoVerde has announced the appointment of Dr Kuldip Birdi as its new Medical Director. 

Dr Kuldip Birdi will help develop AltoVerde’s medical cannabis programmes as it expands from its UK base into Europe.

Dr Birdi has a distinguished career with over 15 years working for both the NHS and the pharmaceutical industry, and is now working to fully unlock the potential of the cannabis plant in partnership with AltoVerde.

Dr Kuldip Birdi

Mitesh Makwana, Founder and Chairman of AltoVerde, said: “The key to unlocking the true potential of medical cannabis is through strong partnerships with the pharmaceutical industry. 

“Only through such means will the pharma truly understand the benefits of cannabis based medicinal products, and the cannabis industry be able to formulate medicinal products in accordance with the country regulations.

“Dr Birdi, with his experience in both sectors is ideally suited for this role, and we look forward to working with him towards bringing greater acceptance of medicinal cannabis products both to the public and the medical sector itself”.

Dr Birdi said: “AltoVerde’s ethos is inspiring. When I was first introduced to the company, I realised immediately how AltoVerde was setting itself apart from its competitors and how unique it would become. 

“I am a true believer in the patient-centred approach to management with medical cannabis which is what the company aims to do. I am excited to be part of the business at this stage and of something which will no doubt grow and shape the medical cannabis industry”.


Peter
Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further signs the UK’s National Health Service is warming to cannabis...

Reakiro – Europe’s Leading CBD And Hemp Brand – Delivers The Complete B2B & B2C Package

IN a time when CBD products are becoming unavoidable in the health, wellness and fitness industries, it is more...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European country to legalise adult-use cannabis have emerged. In an interview on...

Cannabis Is Now A Compelling Opportunity For The Main Tobacco Companies

International cannabis expert, Barbara Pastori, of Prohibition Partners shares her thoughts on why cannabis is a compelling opportunity for...

Oxford Cannabinoid Technologies Holdings Sign Exclusive Worldwide License Agreement With Canopy Growth

Oxford Cannabinoid Technologies Holdings plc (OCTP), the holding company of Oxford Cannabinoid Technologies Ltd (“OCT”) (together, the “Group”), a...

With Global Cannabis Cultivation Capacity Set To Outstrip Demand One Hundredfold – What Happened To The ‘Green’ Rush?

CANNABIS investors need to be wary when it comes to cultivation, says Oliver Zugel, Founder and CEO FoliuMed Holdings. Where...

Must read

Plans Unveiled For First National Health Service-Backed Medical Cannabis Clinical Trial

AFTER launching a patient registry earlier this year further...

Is Luxembourg’s Quest To Introduce An Adult-Use Cannabis Programme Going Up In Smoke?

CONCERNS over Luxembourg’s intent to become the first European...

You might also likeRELATED
Recommended to you